United States · FDA National Drug Code directory

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 31722-186_02105fa1-4728-4954-b2af-8444bf122364
Product NDC: 31722-186
Form: CAPSULE, EXTENDED RELEASE
Composition / generic term: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Labeler: Camber Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20210929
Source listing expiry: 20261231

Source-listed ingredients

DEXTROAMPHETAMINE SACCHARATE — 2.5 mg/1
AMPHETAMINE ASPARTATE MONOHYDRATE — 2.5 mg/1
DEXTROAMPHETAMINE SULFATE — 2.5 mg/1
AMPHETAMINE SULFATE — 2.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-186-01) · 31722-186-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →